Gene · 10657
Papers1,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer. | J Immunol Res | 2022 | 36405012 | PubTator, text mining | PubMed |
| Circular RNAs as diagnostic biomarkers for gastric cancer: A comprehensive update from emerging functions to clinical significances. | Front Genet | 2022 | 36386850 | PubTator, text mining | PubMed |
| Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors. | Front Pharmacol | 2022 | 36386148 | PubTator, text mining | PubMed |
| Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer. | Mol Cancer | 2022 | 36376892 | PubTator, text mining | PubMed |
| RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy. | Cancers (Basel) | 2022 | 36358717 | PubTator, text mining | PubMed |
| The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer. | Nat Struct Mol Biol | 2022 | 36344846 | PubTator, text mining | PubMed |
| hnRNP A1 in RNA metabolism regulation and as a potential therapeutic target. | Front Pharmacol | 2022 | 36339596 | PubTator, text mining | PubMed |
| Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through β-catenin/MDR1 signaling to sustain chemoresistance. | Front Oncol | 2022 | 36330477 | PubTator, text mining | PubMed |
| MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer. | Cell Commun Signal | 2022 | 36307841 | PubTator, text mining | PubMed |
| A Proximity biotinylation assay with a host protein bait reveals multiple factors modulating enterovirus replication. | PLoS Pathog | 2022 | 36306280 | PubTator, text mining | PubMed |
| Foot-and-Mouth Disease Virus: Molecular Interplays with IFN Response and the Importance of the Model. | Viruses | 2022 | 36298684 | PubTator, text mining | PubMed |
| Characterization of the RAS/RAF/ERK Signal Cascade as a Novel Regulating Factor in Alpha-Amanitin-Induced Cytotoxicity in Huh-7 Cells. | Int J Mol Sci | 2022 | 36293151 | PubTator, text mining | PubMed |
| Thermodynamic and structural characterization of an EBV infected B-cell lymphoma transcriptome. | NAR Genom Bioinform | 2022 | 36285286 | PubTator, text mining | PubMed |
| UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. | Oncogene | 2022 | 36273042 | PubTator, text mining | PubMed |
| Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease. | Sci Rep | 2022 | 36266428 | PubTator, text mining | PubMed |
| Global profiling of arginine dimethylation in regulating protein phase separation by a steric effect-based chemical-enrichment method. | Proc Natl Acad Sci U S A | 2022 | 36256816 | PubTator, text mining | PubMed |
| DDX60 selectively reduces translation off viral type II internal ribosome entry sites. | EMBO Rep | 2022 | 36256515 | PubTator, text mining | PubMed |
| Shortening of the KHDRBS1 3'UTR by alternative cleavage and polyadenylation alters miRNA-mediated regulation and promotes gastric cancer progression. | Am J Transl Res | 2022 | 36247240 | PubTator, text mining | PubMed |
| USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma. | Oncogene | 2022 | 36243803 | PubTator, text mining | PubMed |
| Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity. | Int J Mol Sci | 2022 | 36232770 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10657/papers?page=12